CLINICAL TRIAL

Treatment for COVID-19

Recruiting · Any Age · All Sexes · Rockville, MD

Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)

See full description

About the trial for COVID-19

Eligible Conditions
Virus Diseases · COVID-19 · Coronavirus Disease 2019 (COVID‑19)

Treatment Groups

This trial involves 3 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 1 & 2 and have already been tested with other people.

Control Group 1
Inflammation (I)
DIETARYSUPPLEMENT
+
Standard of care
DRUG
Control Group 2
Inflammation (III)
DIETARYSUPPLEMENT
+
Standard of care
DRUG
Control Group 3
Standard of care
DRUG
+
Inflammation (II)
DIETARYSUPPLEMENT

Eligibility

This trial is for patients born any sex of any age. There are 6 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
The age of participants is between 10 and 70 years old. show original
This clinical study involves people of all genders, all ages, all races, and all nationalities. show original
The participants are divided into two groups: those who are receiving conventional medication treatment and those who are not show original
Participants in the study will have to repeat the evaluation experiment at the beginning and the end of the clinical study. show original
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 6 weeks
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 6 weeks.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Treatment will improve 3 primary outcomes and 3 secondary outcomes in patients with COVID-19. Measurement will happen over the course of 3 weeks.

inhibiting inflammation
3 WEEKS
comparing C-reactive protein (CRP)
recovering damaged organ
3 WEEKS
comparing imagen of lungs
tracking the COVID virus marks
3 WEEKS
SARS-CoV-2 Diagnostic (Molecular or Antigen) Testing
correcting reversed immunity ratio
6 WEEKS
measuring cluster of differentiation 4/cluster of differentiation 8 (CD4/CD8)
preventing the antibody depositing on antigen
6 WEEKS
measuring complement: C3, C4
monitoring the antibody level
6 WEEKS
measuring immunoglobulin M (IgM), immunoglobulin G (IgG)

Who is running the study

Principal Investigator
W. H.
Wanzhu Hou, President
All Natural Medicine Clinic, LLC

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are common treatments for covid-19?

As of mid-February, no antiviral drugs or vaccine candidates have proven effective against SARS-CoV-2, but there are antivirals in the pipeline that may have potential. The first trials of the investigational drug remdesivir are underway. There is no combination effective treatment with any specific cure. The primary focus is on supportive treatments and preventing and treating complications. In cases where a virus is detected early and the disease is mild, the recommended preventive approach is minimal, including limiting exposure, as well as basic hygiene and hand washing. The recommended course of action on the basis of the U.S.

Anonymous Patient Answer

What are the signs of covid-19?

Signs and symptoms of acute respiratory infection due to SARS and MERS are similar to clinical presentations of COVID-19, most commonly the flu, with fever, fatigue, myalgia, headache and a cough. Diarrhea may be the first symptom for COVID-19, and patients with diarrhea have a more recent age of onset.

Anonymous Patient Answer

Can covid-19 be cured?

Contrary to what was previously believed, there is no evidence that COVID-19 can be cured. The disease will likely to be lethal in most cases for the majority of people.

Anonymous Patient Answer

How many people get covid-19 a year in the United States?

As of March 10, 2020, approximately 1.3million people have been reported to have the disease, and there has not been a single reported death. As is typically the case with infectious disease outbreaks, a number of cases occur each year. In the case of coronavirus (CoV-19), estimates depend upon the model used, with the highest estimates reported by the "Times" and "Washington Post" based upon their respective models. The model used by the "Times" was reflective of the best estimates, while the model used by the "Washington Post" was reflective of the worst estimates, as these respective papers used different models. The predictions by both of these papers were then combined.

Anonymous Patient Answer

Is treatment typically used in combination with any other treatments?

There is evidence that the current guidelines for treatment of SARS are only loosely informed by the literature and that most commonly employed treatments may be of limited benefit. There is an urgent need for clinical trials to support the effectiveness of most commonly employed therapeutic measures.

Anonymous Patient Answer

What is covid-19?

The outbreak of the 2019-20 coronavirus is the first, and thus far only, widespread epidemic of a coronavirus in human history. Of the seven novel, SARS-CoV-2. The epidemiology and clinical impact of the disease remain unknown, and the disease is caused by a novel coronavirus (CoV), the 2019-Coronavirus (SARS-CoV2).

Anonymous Patient Answer

What causes covid-19?

This paper presents case histories of a series of 9 patients with C19-related disease. The diagnosis was supported by molecular detection in four of the nine and in the absence of such detection, by clinical data in the other five. There was a temporal relationship with an increased exposure to coronaviruses in March 2019. C19 has been reported from China in April 2019, confirming virus persistence in an area with few cases until April. This is the first documentation of C19 in a high-incidence area, and has further suggested it might have broader relevance.

Anonymous Patient Answer

Who should consider clinical trials for covid-19?

Current research indicates that catechol-O-methyltransferase genetic variation contributes significantly to cognitive performance. Findings from a recent study may be useful for planning clinical trials for future cases such as covid-19. A clinical trial for covid-19 should be encouraged when the impact on human cognitive performance is significant and where the current treatment options are either suboptimal or nonexistent.

Anonymous Patient Answer

Does treatment improve quality of life for those with covid-19?

A single, brief outpatient treatment for those with covid-19 resulted in improvements to several aspects of quality of life. Future studies are needed to confirm that these results are sustained outside the lab setting.

Anonymous Patient Answer

How serious can covid-19 be?

According to the World Health Organization (WHO), "[c]ontroversy remains about whether [covid-19] will have a severe impact on health." At the moment we lack sufficient evidence to estimate risks for patients with [covid-19] relative to risks of untreated disease in those infected. We use the WHO's severity classification of mild, moderate, severe and critical and we aim to provide practical advice and to highlight the need for additional research. The severity of [covid-19] is not related to the number of [covid-19] cases. We show the impact that [covid-19] had on hospitals in the UK.

Anonymous Patient Answer

What does treatment usually treat?

The present analysis confirms that influenza and pneumonia usually cause disease symptoms, but also the more rarer diagnoses of encephalitis, meningitis, and acute flaccid myelitis. Many symptoms can be treated via antiviral agents, but the need for admission to hospital in cases of non-infectious disease justifies considering additional imaging. These are the easiest ways to recognize conditions and to make appropriate therapeutic decisions.

Anonymous Patient Answer

Have there been any new discoveries for treating covid-19?

Currently there are trials underway to test the hypothesis that treatment of patients infected with COVID may work, and this treatment could potentially also be used to other similar respiratory infections that can be carried by SARS-CoV-2. There are ongoing and promising studies to evaluate whether it is possible and safe to treat this infectious disease.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for COVID-19 by sharing your contact details with the study coordinator.